000 01947 a2200565 4500
005 20250518053241.0
008 ####s 0 0 eng d
022 _a1758-8340
024 7 _a10.1177/1758835919864236
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGullo, Giuseppe
245 0 0 _aPilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial.
_h[electronic resource]
260 _bTherapeutic advances in medical oncology
_c2019
300 _a1758835919864236 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aJ Eustace, Alex
700 1 _aCanonici, Alexandra
700 1 _aM Collins, Denis
700 1 _aKennedy, Michael J
700 1 _aGrogan, Liam
700 1 _aBreathhnach, Oscar
700 1 _aMcCaffrey, John
700 1 _aKeane, Maccon
700 1 _aMartin, Michael J
700 1 _aGupta, Rajnish
700 1 _aLeonard, Gregory
700 1 _aO'Connor, Miriam
700 1 _aCalvert, Paula M
700 1 _aDonnellan, Paul
700 1 _aWalshe, Janice
700 1 _aMcDermott, Enda
700 1 _aScott, Kathleen
700 1 _aHernando, Andres
700 1 _aParker, Imelda
700 1 _aW Murray, David
700 1 _aC O'Farrell, Alice
700 1 _aMaratha, Ashwini
700 1 _aDicker, Patrick
700 1 _aRafferty, Mairin
700 1 _aMurphy, Verena
700 1 _aO'Donovan, Norma
700 1 _aM Gallagher, William
700 1 _aKy, Bonnie
700 1 _aTryfonopoulos, Dimitrios
700 1 _aMoulton, Brian
700 1 _aT Byrne, Annette
700 1 _aCrown, John
773 0 _tTherapeutic advances in medical oncology
_gvol. 11
_gp. 1758835919864236
856 4 0 _uhttps://doi.org/10.1177/1758835919864236
_zAvailable from publisher's website
999 _c29977762
_d29977762